Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Fucoidan attenuates 6-hydroxydopamine-induced neurotoxicity by exerting anti-oxidative and anti-apoptotic actions in SH-SY5Y cells

  • Kim, Myung-Hwan (College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University) ;
  • Namgoong, Hoon (College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University) ;
  • Jung, Bae-Dong (College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University) ;
  • Kwon, Myung-Sang (College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University) ;
  • Choi, Yeon-Shik (Department of Laboratory Animal Science, Korea Biopolytechnic College) ;
  • Shin, Taekyun (College of Veterinary Medicine, Jeju National University) ;
  • Kim, Hyoung-Chun (College of Pharmacy, Kangwon National University) ;
  • Wie, Myung-Bok (College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University)
  • Received : 2016.10.11
  • Accepted : 2016.12.14
  • Published : 2017.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Parkinson's disease (PD) is an irreversible neurological disorder with related locomotor dysfunction and is characterized by the selective loss of nigral neurons. PD can be experimentally induced by 6-hydroxydopamine (6-OHDA). It has been reported that reactive oxygen species, which deplete endogenous glutathione (GSH) levels, may play important roles in the dopaminergic cell death characteristic of PD. Fucoidan, a sulfated algal polysaccharide, exhibits anti-inflammatory and anti-oxidant actions. In this study, we investigated whether fucoidan can protect against 6-OHDA-mediated cytotoxicity in SH-SY5Y cells. Cytotoxicity was evaluated by using MTT and LDH assays. Fucoidan alleviated cell damage evoked by 6-OHDA dose-dependently. Fucoidan reduced the number of apoptotic nuclei and the extent of annexin-V-associated apoptosis, as revealed by DAPI staining and flow cytometry. Elevation of lipid peroxidation and caspase-3/7 activities induced by 6-OHDA was attenuated by fucoidan, which also protected against cytotoxicity evoked by buthionine-sulfoximine-mediated GSH depletion. Reduction in the glutathione/glutathione disulfide ratio induced by 6-OHDA was reversed by fucoidan, which also inhibited 6-OHDA-induced disruption of mitochondrial membrane potential. The results indicate that fucoidan may have protective action against 6-OHDA-mediated neurotoxicity by modulating oxidative injury and apoptosis through GSH depletion.

Keywords

References

  1. Blandini F, Armentero MT, Martignoni E. The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 2008, 14 (Suppl 2), S124-129. https://doi.org/10.1016/j.parkreldis.2008.04.015
  2. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001, 65, 135-172. https://doi.org/10.1016/S0301-0082(01)00003-X
  3. Chang GC, Kim HC, Wie MB. Neuroprotective effects of resveratrol on 6-hydroxydopamine-induced damage of SHSY5Y cell line. Korean J Vet Res 2014, 54, 1-6. https://doi.org/10.14405/kjvr.2014.54.1.1
  4. Cui YQ, Jia YJ, Zhang T, Zhang QB, Wang XM. Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neurosci Ther 2012, 18, 827-833. https://doi.org/10.1111/j.1755-5949.2012.00372.x
  5. Cui YQ, Zhang LJ, Zhang T, Luo DZ, Jia YJ, Guo ZX, Zhang QB, Wang X, Wang XM. Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharideactivated primary microglia. Clin Exp Pharmacol Phyiol 2010, 37, 422-428. https://doi.org/10.1111/j.1440-1681.2009.05314.x
  6. Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson's disease. J Parkinsons Dis 2013, 3, 461-491.
  7. Gao Y, Dong C, Yin J, Shen J, Tian J, Li C. Neuroprotective effect of fucoidan on $H_2O_2$-induced apoptosis in PC12 cells via activation of the PI3K/Akt pathway. Cell Mol Neurobiol 2012, 32, 523-529. https://doi.org/10.1007/s10571-011-9792-0
  8. Hanrott K, Gudmusen L, O'Neill MJ, Wonnacott S. 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase-3 dependent activation of protein kinase $C{\delta}$. J Biol Chem 2005, 281, 5373-5382.
  9. Jhamandas JH, Wie MB, Harris K, MacTavish D, Kar S. Fucoidan inhibits cellular and neurotoxic effects of ${\beta}$-amyloid ($A{\beta}$) in rat cholinergic basal forebrain neurons. Eur J Neurosci 2005, 21, 2649-2659. https://doi.org/10.1111/j.1460-9568.2005.04111.x
  10. Kaur D, Lee D, Ragapolan S, Anderson JK. Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease. Free Radic Biol Med 2009, 46, 593-598. https://doi.org/10.1016/j.freeradbiomed.2008.11.012
  11. Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur J Pharmacol 2009, 617, 33-40. https://doi.org/10.1016/j.ejphar.2009.06.015
  12. Martin HL, Teismann P. Glutathione-a review on its role and significance in Parkinson's disease. FASEB J 2009, 23, 3263-3272. https://doi.org/10.1096/fj.08-125443
  13. Meenakshi S, Umayaparvathi S, Saravanan R, Manivasagam T, Balasubramanian T. Neuroprotective effect of fucoidan from Turbinaria decurrens in MPTP intoxicated Parkinsonic mice. Int J Biol Macromol 2016, 86, 425-433. https://doi.org/10.1016/j.ijbiomac.2015.12.025
  14. Orr CF, Rowe DB, Halliday GM. An inflammatory review of Parkinson's disease. Prog Neurobiol 2002, 68, 325-340. https://doi.org/10.1016/S0301-0082(02)00127-2
  15. Owen AD, Schapira AHV, Jenner P, Marsden CD. Oxidative stress and Parkinson's disease. Ann N Y Acad Sci 1996, 786, 217-723. https://doi.org/10.1111/j.1749-6632.1996.tb39064.x
  16. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 2004, 318, 215-224. https://doi.org/10.1007/s00441-004-0938-y
  17. Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med 2013, 62, 13-25. https://doi.org/10.1016/j.freeradbiomed.2013.05.001
  18. Wang T, Zhu M, He ZZ. Low-molecular-weight fucoidan attenuates mitochondrial dysfunction and improves neurological outcome after traumatic brain injury in aged mice: involvement of Sirt3. Cell Mol Neurobiol 2016, 36, 1257-1268. https://doi.org/10.1007/s10571-015-0323-2
  19. Widnell K. Pathophysiology of motor fluctuation in Parkinson's disease. Mov Disord 2005, 20 (Suppl 11), S17-22. https://doi.org/10.1002/mds.20459
  20. Wullner U, Loschmann PA, Schulz JB, Schmid A, Dringen R, Eblen F, Turski L, Klockgether T. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurons. Neuroreport 1996, 7, 921-923. https://doi.org/10.1097/00001756-199603220-00018
  21. Yang JW, Yoon SY, Oh SJ, Kim SK, Kang KW. Bifunctional effects of fucoidan on the expression of inducible nitric oxide synthase. Biochem Biophys Res Commun 2006, 346, 345-350. https://doi.org/10.1016/j.bbrc.2006.05.135
  22. Zhang FL, He Y, Zheng Y, Zhang WJ, Wang Q, Jia YJ, Song HL, An HT, Zhang HB, Qian YJ, Tong YL, Dong L, Wang XM. Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: role of NADPH oxidase-1. CNS Neurosci Ther 2014, 20, 1036-1044. https://doi.org/10.1111/cns.12340

Cited by

  1. Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/6565396